Nigel Walder - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Nigel Walder’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Enterprise Software,
- Transportation,
- Cryptocurrency,
- Life Science,
- Automotive,
- Artificial Intelligence (AI),
- Information Technology (IT),
- Analytics,
- Cloud Computing,
- Mobile,
- Software,
- Virtualization,
- Biotechnology,
- Productivity Software,
- FinTech,
- Consulting,
- Insurance,
- UK-based Startups,
- Developer Tools,
- Medical,
- Big Data,
- Real Estate,
- Therapeutics,
- Media and Entertainment,
- Machine Learning,
- Pharmaceuticals
Social media:
Past investments:
- Cerevel Therapeutics
- QuVa Pharma
- Newlinks Technology
- JPMorgan
- Nutanix
- Brillio
Investor Profile
Nigel Walder is a Venture Capital, Private Equity Firm, Investment Partner, Investor based in London, England, United Kingdom with a diverse investment portfolio that includes companies such as Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, JPMorgan, Nutanix, Brillio, . Over time, Nigel Walder has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Nigel Walder is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Enterprise Software, Transportation, Cryptocurrency, Life Science, Automotive, Artificial Intelligence (AI), Information Technology (IT), Analytics, Cloud Computing, Mobile, Software, Virtualization, Biotechnology, Productivity Software, FinTech, Consulting, Insurance, UK-based Startups, Developer Tools, Medical, Big Data, Real Estate, Therapeutics, Media and Entertainment, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with Nigel Walder, as their portfolio suggests a familiarity and interest in this area.
Understanding Nigel Walder’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
